-
Citi Starts Acumen Pharmaceuticals, Inc. (ABOS) at Buy, 'Targeting Amyloid Beta Oligomers as a Differentiated Strategy in Alzheimer’s'
-
Acumen Pharmaceuticals (ABOS) Prices Upsized 16.77M Share Offering at $7.75/sh
-
Acumen Announces Pricing of Upsized $130 Million Public Offering
-
Acumen Pharmaceuticals (ABOS) Announces $100M Proposed Public Offering of Common Stock
-
Acumen Pharmaceuticals Announces Proposed Public Offering of Common Stock


